Bank of New York Mellon Corp
BankPosition in NBIX — Neurocrine Biosciences Inc
CIK 1390777
NEW YORK, NY
Position in NBIX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$117,830,519
+$25,284,231 QoQ
Shares Held
699,125
-0.5% QoQ
Ownership
0.688%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#22
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $117,830,519 | 699,125 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $92,546,288 | 702,492 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $104,766,410 | 738,676 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $106,884,763 | 761,396 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $97,865,997 | 778,630 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $91,652,223 | 828,682 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $118,794,581 | 870,290 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $98,887,559 | 858,250 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $128,639,392 | 934,404 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $127,070,515 | 921,335 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $129,000,938 | 979,060 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $173,181,594 | 1,539,392 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $149,862,968 | 1,589,215 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $167,216,346 | 1,652,009 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $201,223,308 | 1,684,723 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $184,906,821 | 1,740,955 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $166,049,082 | 1,703,417 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $159,664,965 | 1,703,093 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $158,585,599 | 1,861,989 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $182,425,320 | 1,902,047 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $196,161,203 | 2,015,631 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $187,901,293 | 1,932,147 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $112,305,715 | 1,171,682 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $106,997,900 | 1,112,707 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $118,669,278 | 972,699 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $71,228,655 | 822,977 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||